Xconomy: deals News, Articles and Opinions

“deals” Archives

Entry	Author	Date	Location
MagniX, Eviation Partner to Develop Electric Plane For Short Flights	Jeff Buchanan	04/22/19	Seattle
TerraClear Raises $4.7M for Machine Designed to Pick Rocks from Soil	Jeff Buchanan	04/19/19	Seattle
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More	Ben Fidler	04/19/19	National
Bardy Diagnostics to Ramp Up Cardiac Monitor Sales With $35M Raise	Jeff Buchanan	04/18/19	Seattle
Hookipa’s IPO Raises $84M for Drugs to Reprogram the Immune System	Frank Vinluan	04/18/19	New York
It’s Tough to Find Drugs to Bind to RNA: Arrakis Nabs $75M to Help	Frank Vinluan	04/18/19	Boston
$100M for Talaris Gives Surgeon a Shot to Reinvent Organ Transplants	Ben Fidler	04/18/19	Boston
Seattle’s Outreach Joins Unicorn Ranks With $114M Funding Round	Jeff Buchanan	04/16/19	Seattle
6sense Raises $27M to Uncover Hidden Interests of B2B Buyers	Bernadette Tansey	04/16/19	San Francisco
Founders’ Co-op Raises $25M to Back More Pacific Northwest Startups	Jeff Buchanan	04/16/19	Seattle
Show Me The Money: Seattle’s Showdigs Gets $3M for Real Estate Tools	Jeff Buchanan	04/15/19	Seattle
Another Week, Another Gene Therapy Buyout: Catalent Pays $1.2B for Paragon	Ben Fidler	04/15/19	New York
Lyft, Uber, and the Changing Disclosure Rules For Unicorn IPOs	Bernadette Tansey	04/12/19	San Francisco
Thwarting Opposition, Bristol Gets Shareholder OK for $74B Celgene Buyout	Ben Fidler	04/12/19	New York
Boston Tech Watch: Tufin, Facebook, RightHand, Diameter & Jebbit	Brian Dowling	04/12/19	Boston
WI Watchlist: DotCom Therapy, Nordic, UWM, Epic	Jeff Engel	04/11/19	Wisconsin
AskBio Reels In $235M to Advance Gene Therapy Clinical Trials	Frank Vinluan	04/11/19	Raleigh Durham
Apana Gulps Down $11M to Help Costco, Other Clients Track Water Use	Jeff Buchanan	04/09/19	Seattle
Sobriety Pays: DynamiCare Gamifies Staying Clean for Recovering Addicts	Brian Dowling	04/09/19	Boston
VC Trends in 2019: More Money, Fewer Deals But Women Still Get Less	David Holley	04/09/19	National
RiskLens Raises $20M for Software That Quantifies Cyber Risk	Jeff Buchanan	04/08/19	Seattle
Alnylam Gets $800M From Regeneron to Bring RNAi to Eye, Brain Diseases	Ben Fidler	04/08/19	Boston
Bio Roundup: Gottlieb’s Goodbye, AACR Recap, Migraine Drug Fight & More	Frank Vinluan	04/05/19	National
NGM Bio’s IPO Raises $107M as NASH Drug Continues Clinical Testing	Frank Vinluan	04/03/19	San Francisco
Dyne Therapeutics Emerges With $50M to Take On Rare Muscle Disease	Frank Vinluan	04/03/19	Boston
Lear to Acquire Seattle Connected Vehicle Tech Firm Xevo For $320M	Jeff Buchanan	04/02/19	Seattle
Seattle Venture Capital Watch: Crelate, Cyemptive, Blue Canoe & More	Jeff Buchanan	04/02/19	Seattle
EzCater Celebrates “Unicorn” Status After $150M Funding Round	Brian Dowling	04/02/19	Boston
SpringWorks, Armed with Ex-Pfizer Cancer Drugs, Reloads with $125M	Ben Fidler	04/01/19	New York
Novartis Adds Inflammation Drugs to Pipeline with Deal for IFM Tre	Frank Vinluan	04/01/19	Boston
Page 1 of 287	next page »